![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
| Item Type: | Article |
|---|---|
| Title: | Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4 |
| Creators Name: | Kircher, T., Pantsar, T., Oder, A., von Kries, J.P., Juchum, M., Pfaffenrot, B., Kloevekorn, P., Albrecht, W., Selig, R. and Laufer, S. |
| Abstract: | The mitogen-activated protein kinase kinase 4 (MKK4) plays a key role in liver regeneration and is under investigation as a target for stimulating hepatocytes to increased proliferation. Therefore, new small molecules inhibiting MKK4 may represent a promising approach for treating acute and chronic liver diseases. Fluorescently labeled compounds are useful tools for high-throughput screenings of large compound libraries. Here we utilized the azaindole-based scaffold of FDA-approved BRAF inhibitor vemurafenib 1, which displays off-target activity on MKK4, as a starting point in our fluorescent compound design. Chemical variation of the scaffold and optimization led to a selection of fluorescent 5-TAMRA derivatives which possess high binding affinities on MKK4. Compound 45 represents a suitable tool compound for Fluorescence polarization assays to identify new small-molecule inhibitors of MKK4. |
| Keywords: | Mitogen-Activated Protein Kinase Kinase 4, Vemurafenib, Fluorescence Polarization Assay |
| Source: | European Journal of Medicinal Chemistry |
| ISSN: | 0223-5234 |
| Publisher: | Elsevier |
| Volume: | 2019 |
| Page Range: | 112901 |
| Date: | 1 January 2021 |
| Additional Information: | Copyright © 2020 Elsevier Masson SAS. All rights reserved. |
| Official Publication: | https://doi.org/10.1016/j.ejmech.2020.112901 |
| External Fulltext: | View full text on external repository or document server |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
